• 제목/요약/키워드: Kidney Cancer

검색결과 363건 처리시간 0.025초

SARS-CoV-2 infection induces expression and secretion of lipocalin-2 and regulates iron in a human lung cancer xenograft model

  • Sangkyu Park;Dongbum Kim;Jinsoo Kim;Hyung-Joo Kwon;Younghee Lee
    • BMB Reports
    • /
    • 제56권12호
    • /
    • pp.669-674
    • /
    • 2023
  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection leads to various clinical symptoms including anemia. Lipocalin-2 has various biological functions, including defense against bacterial infections through iron sequestration, and it serves as a biomarker for kidney injury. In a human protein array, we observed increased lipocalin-2 expression due to parental SARS-CoV-2 infection in the Calu-3 human lung cancer cell line. The secretion of lipocalin-2 was also elevated in response to parental SARS-CoV-2 infection, and the SARS-CoV-2 Alpha, Beta, and Delta variants similarly induced this phenomenon. In a Calu-3 implanted mouse xenograft model, parental SARSCoV-2 and Delta variant induced lipocalin-2 expression and secretion. Additionally, the iron concentration increased in the Calu-3 tumor tissues and decreased in the serum due to infection. In conclusion, SARS-CoV-2 infection induces the production and secretion of lipocalin-2, potentially resulting in a decrease in iron concentration in serum. Because the concentration of iron ions in the blood is associated with anemia, this phenomenon could contribute to developing anemia in COVID-19 patients.

위에 발생한 악성 횡문근양 종양의 영상 소견: 증례 보고 (Imaging Findings of a Malignant Rhabdoid Tumor in the Stomach: A Case Report)

  • 윤혜란;박동희;공준석
    • 대한영상의학회지
    • /
    • 제82권2호
    • /
    • pp.493-497
    • /
    • 2021
  • 악성 횡문근양 종양은 주로 영유아의 신장에서 발생하는 공격적인 종양이다. 신장 이외의 조직에서 발생한 경우 신외성 악성 횡문근양 종양이라 하고 중추신경계, 간, 뇌, 피부, 연조직 등에서 드물게 보고되었다. 위에서 발생한 악성 횡문근양 종양은 매우 드물다. 저자들은 흑색변을 주소로 내원한 72세 남자의 위에서 발견된 악성 신외성 횡문근양 종양이 림프종과 유사한 영상 소견을 보인 예를 경험하여 보고한다.

Socioeconomic Impact of Cancer in Member Countries of the Association of Southeast Asian Nations (ASEAN): the ACTION Study Protocol

  • Kimman, Merel;Jan, Stephen;Kingston, David;Monaghan, Helen;Sokha, Eav;Thabrany, Hasbullah;Bounxouei, Bounthaphany;Bhoo-Pathy, Nirmala;Khin, Myo;Cristal-Luna, Gloria;Khuhaprema, Thiravud;Hung, Nguyen Chan;Woodward, Mark
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제13권2호
    • /
    • pp.421-425
    • /
    • 2012
  • Cancer can be a major cause of poverty. This may be due either to the costs of treating and managing the illness as well as its impact upon people's ability to work. This is a concern that particularly affects countries that lack comprehensive social health insurance systems and other types of social safety nets. The ACTION study is a longitudinal cohort study of 10,000 hospital patients with a first time diagnosis of cancer. It aims to assess the impact of cancer on the economic circumstances of patients and their households, patients' quality of life, costs of treatment and survival. Patients will be followed throughout the first year after their cancer diagnosis, with interviews conducted at baseline (after diagnosis), three and 12 months. A cross-section of public and private hospitals as well as cancer centers across eight member countries of the Association of Southeast Asian Nations (ASEAN) will invite patients to participate. The primary outcome is incidence of financial catastrophe following treatment for cancer, defined as out-of-pocket health care expenditure at 12 months exceeding 30% of household income. Secondary outcomes include illness induced poverty, quality of life, psychological distress, economic hardship, survival and disease status. The findings can raise awareness of the extent of the cancer problem in South East Asia and its breadth in terms of its implications for households and the communities in which cancer patients live, identify priorities for further research and catalyze political action to put in place effective cancer control policies.

Profiling of Gene Expression According to Cancer Stage in Clear Cell Type of Renal Cell Carcinoma

  • Won, Nam-Hee;Ryu, Yeon-Mi;Kim, Ki-Nam;Kim, Meyoung-Kon
    • Molecular & Cellular Toxicology
    • /
    • 제1권1호
    • /
    • pp.62-71
    • /
    • 2005
  • For toxicity model in the kidney, renal cell carcinoma (RCC) is one of the most important model to assess the structural and functional alterations. Most RCCs are sporadic, and environmental agents are suspected to play a role in the etiology of the disease. In this study, we discovered novel evidence for previously unknown gene expression patterns related to progression according to cancer stage in RCC. Four clear cell RCC tissue samples along with five corresponding patient-matched normal kidney tissue samples were obtained from patients undergoing partial or radical nephrectomy. To examine the difference of gene expression profile in clear cell RCC, radioactive cDNA microarrays were used to evaluate changes in the expression of 1,152 genes in a total. Using $^{33}P-labeled$ probes, this method provided highly sensitive gene expression profiles including drug metabolism, and cellular signaling. 29 genes were identified with expression levels that differed by more than 2.0 value of z-ratio, compared with that in control. Whereas expression of 38 genes were decreased by less than-2.0 value of z-ratio. In conclusion, this study has identified 67 gene expression alterations in clear-cell type of RCC. Most notably, genes involved in cell growth were up-regulated in stage I more than stage III whereas genes involved in signal transduction were down-regulated in which both stage I and stage III. The identified alteraions of gene expression will likely give in sight in to clear cell RCC and tumor progression.

Clinical Prognostic Factors and Survival Outcome in Renal Cell Carcinoma Patients - A Malaysian Single Centre Perspective

  • Yap, Ning Yi;Ng, Keng Lim;Ong, Teng Aik;Pailoor, Jayalakshmi;Gobe, Glenda Carolyn;Ooi, Chong Chien;Razack, Azed Hassan;Dublin, Norman;Morais, Christudas;Rajandram, Retnagowri
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제14권12호
    • /
    • pp.7497-7500
    • /
    • 2013
  • Background: This study concerns clinical characteristics and survival of renal cell carcinoma (RCC) patients in University Malaya Medical Centre (UMMC), as well as the prognostic significance of presenting symptoms. Materials and Methods: The clinical characteristics, presenting symptoms and survival of RCC patients (n=151) treated at UMMC from 2003-2012 were analysed. Symptoms evaluated were macrohaematuria, flank pain, palpable abdominal mass, fever, lethargy, loss of weight, anaemia, elevated ALP, hypoalbuminemia and thrombocytosis. Univariate and multivariate Cox regression analyses were performed to determine the prognostic significance of these presenting symptoms. Kaplan Meier and log rank tests were employed for survival analysis. Results: The 2002 TNM staging was a prognostic factor (p<0.001) but Fuhrman grading was not significantly correlated with survival (p=0.088). At presentation, 76.8% of the patients were symptomatic. Generally, symptomatic tumours had a worse survival prognosis compared to asymptomatic cases (p=0.009; HR 4.74). All symptoms significantly affect disease specific survival except frank haematuria and loin pain on univariate Cox regression analysis. On multivariate analysis adjusted for stage, only clinically palpable abdominal mass remained statistically significant (p=0.027). The mean tumour size of palpable abdominal masses, $9.5{\pm}4.3cm$, was larger than non palpable masses, $5.3{\pm}2.7cm$ (p<0.001). Conclusions: This is the first report which includes survival information of RCC patients from Malaysia. Here the TNM stage and a palpable abdominal mass were independent predictors for survival. Further investigations using a multicentre cohort to analyse mortality and survival rates may aid in improving management of these patients.

Annexin A5 as a New Potential Biomarker for Cisplatin-Induced Toxicity in Human Kidney Epithelial Cells

  • Kwon, Yeo-Jung;Jung, Jin-Joo;Park, Na-Hee;Ye, Dong-Jin;Kim, Donghak;Moon, Aree;Chun, Young-Jin
    • Biomolecules & Therapeutics
    • /
    • 제21권3호
    • /
    • pp.190-195
    • /
    • 2013
  • Cisplatin is a member of platinum-containing anti-cancer drugs that causes cross-linking of DNA and ultimately cancer cell apoptosis. The therapeutic function of cisplatin on various types of cancers has been widely reported but the side effects have been discovered together and nephrotoxicity has been regarded as major side effect of cisplatin. To select candidates for new sensitive nephrotoxicity biomarker, we performed proteomic analysis using 2-DE/MALDI-TOF-MS followed by cisplatin treatment in human kidney cell line, HK-2 cells, and compared the results to the gene profile from microarray composed of genes changed in expression by cisplatin from formerly reported article. Annexin A5 has been selected to be the most potential candidate and it has been identified using Western blot, RT-PCR and cell viability assay whether annexin A5 is available to be a sensitive nephrotoxic biomarker. Treatment with cisplatin on HK-2 cells caused the increase of annexin A5 expression in protein and mRNA levels. Over-expression of annexin A5 blocked HK-2 cell proliferation, indicating correlation between annexin A5 and renal cell toxicity. Taken together, these results suggest the possibility of annexin A5 as a new biomarker for cisplatin-mediated nephrotoxicity.

동물체모 및 장기 중 카드뮴의 방사화 분석 (Neutron Activation Analysis of Cadmium Deposition in Hair and Animal Tissues)

  • 유용운;이기호
    • Journal of Radiation Protection and Research
    • /
    • 제15권2호
    • /
    • pp.17-25
    • /
    • 1990
  • 백서의 장기 내 카드뮴의 축적분포를 중성자 조사에 의한 방사분석법으로 조사하였다. $CdCl_2$를 1주일에 10mg/kg씩 급식되도록 매일 물병으로 투여하였으며 1주, 2주, 3주, 1개월, 2개월 및 3개월 기간동안 장기 복용케한 후 주요장기 및 체모를 시료로 하여 방사화 분석을 수행하여 아래와 같은 결론을 얻었다. 1) $^{115m}Cd$을 방사추적자로 사용하여 24시간 경과 후 체내 카드뮴의 분포를 조사한 결과 혈액에 0.03% 신장에 2.99% 간장에 3.50%를 나타내었다. 2) Cd은 혈액을 통해 신속히 순환되어 신장을 통하여 배설되나 간장과 체모에도 축적되는 결과를 나타냈다. 3) $CdCl_2$를 급식케 한 실험군의 주요 장기별 Cd함량을 측정 비교한 결과를 이용하여 간장 내 Cd의 축적을 체모 내 Cd함량으로부터 진단하는 지표로 사용이 가능케 되었다.

  • PDF

Biodistribution of [S-35] Labeled Antisense Oligodeoxynucleotides Increased Tumor Targeting With Microsphere Coinjection

  • Choe, Jae-Gol;Park, Gil-Hong;Claudio Nastruzzi;Yoon S. Cho-Chung;Kim, Meyoung-Kon
    • 한국환경성돌연변이발암원학회지
    • /
    • 제22권2호
    • /
    • pp.65-69
    • /
    • 2002
  • To elucidate the effect of microsphere coinjection on the administration of oligodeoxynucleotides (ODN), we have investigated biodistribution of [S-35]-labeled antisense ODN targeted to cAMP-dependent protein kinase (PKA) RI-$\alpha$ subunit in nude mice xenografted with WiDr (human colon cancer, ATCC CCL218). The strategy of using microsphere has been proposed for cancer treatment as a carrier of therapeutic ODN so that it could offer an advantage with respect to maintaining constant ODN levels in blood and obtaining higher therapeutic ODN concentration at tumor sites. Comparative biodistribution studies were performed in nude mice (female, 20 g of body weight, n = 4-6) xenografted with WiDr cancer cells, when 0.1 $\mu$Ci (specific activity, 2.94 mCi/$\mu$mole) of [S-35]-labeled RI-$\alpha$ antisense ODN was injected alone or with microsphere (PLG-18, polylactic copolymer with cationic surfactant DDAB18). Peak tumor uptake of [S-35]-labeled ODN was significantly increased from 17.7% (at 6 h) of injected dose per gram of tissue (ID/g) to 42.5% (at 24 h) ID/g when microsphere was coinjected with ODN. The different biodistribution in the kidney accumulation (e.g., 100.2% ID/g for ODN alone and 54.9%/ID/g for microshpere coinjection) may contribute to higher blood concentration (e.g., 21.5%ID/$m\ell$ for ODN alone and 37.5%ID/$m\ell$ for microsphere coinjection) of radiolabeled ODN. Of importance is the fact that the whole body retention of radioactivity increased with microsphere coinjection from 50.8%ID/g to 68.0%ID/g after 24-h of injection. This decreased kidney accumulation and increased whole body retention of [S-35]-labeled ODN resulted in a significant improvement of ODN targeting to the tumor site. In conclusion, the coinjection of microsphere appears to be an important carrier system in vehiculation of antisense oligonucleotide to the tumor tissue in vivo.

  • PDF

Lactobacillus casei의 배양물에서 분리한 물질의 항암 효과 (Anti-Cancer Effects of Peptides Purified from Culture Supernatant of Lactobacillus casei)

  • 김정화;김동명;백홍;이승훈;정명준
    • Journal of Dairy Science and Biotechnology
    • /
    • 제26권1호
    • /
    • pp.5-10
    • /
    • 2008
  • 최근 유산균에 대한 관심이 많아지고 그와 관련된 수많은 제품들이 제조되고 유통되고 있다. 이러한 유산균의 기능으로는 가장 먼저 정장 작용을 들 수 있고, 그 외 항암 효과, 유당 단백질의 흡수 증진, 혈청 콜레스테롤의 저하 등 많은 기능을 가지고 있다. 이에 따라 유산균의 한 종류인 Lactobacillus casei의 배양물로부터 단백질을 분리한 것으로 Ultrafiltration membrane (3, 10, 30, 100 KDa)으로 분리 농축한 단백질 물질인 단백질성분 A(protein components A)와 단백질 성분 B(protein components B)을 분리하여 실험에 사용하였고, 이 물질을 이용하여 보다 세밀한 분리를 위해 FPLC(fast protein liquid chromatography, sephadex 75, Amersham)를 이용하여 분석된 peak를 이용하여 3번부터 9번까지 분획물을 얻어 실험에 사용하였다. 위에서 얻은 단백질 물질들을 이용하여 정상 세포와 암세포주를 이용하여 세포 독성 및 암세포 생육 억제 활성을 측정한 결과, 단백질 성분 A(protein components A)와 단백질 성분 B(protein components B)의 물질에서 최적 농도인 $100{\mu}g/mL$의 농도에서 정상 세포에 대한 세포 독성은 20% 정도로 낮은 세포 독성 효과를 나타내 정상 세포에 대한 독성 효과는 없는 것으로 나타났고, 5가지 암세포주(위암, 폐암, 유방암, 난소암, 대장암)에 대한 암세포 생육 억제 활성에서는 70% 정도의 높은 암세포 생육 억제 효과를 나타내 항암 효과를 나타냈다. 그리고 FPLC를 이용하여 분리한 분획물에서는 3, 8, 9번 분획물에서는 정상 세포에 대한 세포독성이 50%를 나타내 독성 효과를 나타냈고, 그 외의 분획물에서는 정상 세포에 대한 독성이 나타나지 않았다. 그 중 7번 분획물에서 암세포에 대한 생육 억제 활성을 나타낸 결과, 70% 정도의 높은 암세포 생육 억제 활성을 나타내 항암활성을 지닌 성분으로 확인하였다. 그 외의 분획물에서는 거의 효과를 나타내지 않았다. 따라서 Lactobacillus casei의 배양물에서 분리한 성분이 항암 효과를 나타내고 있는 것을 확인하였다.

  • PDF

Effects of Ulmi Pumilae Cortex on AGS Gastric Cancer Cells

  • Lim, Bora;Lee, Hee Jung;Kim, Min Chul;Kim, Byung Joo
    • 대한약침학회지
    • /
    • 제16권2호
    • /
    • pp.55-61
    • /
    • 2013
  • Objective: Ulmi Pumilae Cortex (UPC) is a deciduous tree with uneven pinnate leaves and is classified as a subfamily of Ulmuceae and contains many pharmacologically active constituents. The aim of this study was to investigate the effects of UPC on the growth and survival of AGS cells, the most common human gastric adenocarcinoma cell lines. Methods: The AGS cells were treated with varying concentrations of UPC. Analyses of the sub G1, caspase-3 activity, and mitochondrial depolarization were conducted to determine whether AGS cell death occured by apoptosis. Furthermore, to identify the role of the transient receptor potential melastatin (TRPM) 7 channels in AGS cell growth and survival, we used human embryonic kidney (HEK) 293 cells overexpressed with TRPM7 channels. Results: The addition of UPC to a culture medium inhibited AGS cell growth and survival. Experimental results showed that the sub G1, caspase-3 activity, and mitochondrial depolarization were increased. Furthermore, TRPM7 channel overexpression in HEK 293 cells exacerbated UPC-induced cell death. Conclusion: These findings indicate that UPC inhibits the growth and survival of gastric cancer cells due to a blockade of the TRPM7 channel activity. Therefore, UPC is a potential drug for treatment of gastric cancer, and TRPM7 channels may play an important role in survival in cases of gastric cancer.